Vista, CANCT07871513Now EnrollingIRB Ready

Upper Facial Lines Clinical Trial in Vista, CA

Access cutting-edge upper facial lines treatment through this phase 2 clinical trial at a research site in Vista. Study-provided care at no cost to qualified participants.

Sponsored by AbbVie

Quick Self-Assessment

See if you qualify for this Vista location

Preparing your pre-screening questions…

Expert Care in Vista

Access upper facial lines specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related upper facial lines treatment provided free

Apply for This Vista Location

Check if you qualify for this upper facial lines clinical trial in Vista, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Vista

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Vista site if eligible
  4. 4Begin participation

About This Upper Facial Lines Study in Vista

The objective of this Phase 2 study is to assess the safety and efficacy of single treatment of trenibotulinumtoxinE and onabotulibumtoxinA combination in adult participants with moderate to severe upper facial lines. The study has two parts; Part 1 evaluates treatment for glabellar lines.

Sponsor: AbbVie

Who Can Participate

Inclusion Criteria

For glabellar lines (GL) indication: participant must have moderate or severe GL at maximum furrow as assessed by both the investigator and participant using the AGLSS at Screening and Baseline (Day 1) visits.
Participant must be in good health as per investigator's judgment based on medical history, physical examination, vital sign measurements, 12-lead electrocardiogram (ECG) parameters, clinical laboratory evaluations, and neurological assessment.
In the investigator's opinion, participant must not have a condition or be in a situation that may put the participant at significant risk, may confound the study results, or may interfere significantly with the participant's participation in the study.

Exclusion Criteria

For GL Indication: Severe GL at rest as assessed by the investigator using the AGLSS at Screening or Baseline (Day 1).
History of immunization to any botulinum neurotoxin serotype or hypersensitivity to any botulinum neurotoxin serotype or any other constituents of the study drug or its excipients
Active infection or dermatological condition at the treatment injection sites.
Medical condition that may put the subject at increased medical risk with exposure to botulinum toxin, including diagnosed myasthenia gravis, Lambert-Eaton syndrome, amyotrophic lateral sclerosis, or any other condition that might interfere with neuromuscular function

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Vista?

Yes, this clinical trial (NCT07871513) has an active research site in Vista, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Upper Facial Lines Treatment Options in Vista, CA

If you're searching for upper facial lines treatment options in Vista, CA, this clinical trial (NCT07871513) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Vista research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced upper facial lines specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all upper facial lines clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Vista, CA

See all pulmonary embolism clinical trials recruiting in Vista — not just this study.

Browse Pulmonary Embolism Trials in Vista →

Browse More Trials by Condition

Pulmonary Embolism TrialsFanconi Anemia TrialsAll Conditions →

Ready to Join in Vista?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Vista, CA